Filing metadata

Accession number
0001104659-24-065121
Form type
Form 3
Filer
Checkpoint Therapeutics, Inc.
CIK
CIK 1651407
Filed
May 24, 2024
Reporting period
May 16, 2024
Description
Initial ownership

Explore SEC Filings Hub